Particle.news
Health ❯Medicine ❯Pharmaceuticals
Obesity Treatments Clinical Trials Alzheimer's Disease Cancer Treatments Inflammatory Bowel Disease Weight Loss Treatments Pain Medication Muscle-Activating Compounds ERR Protein Activation Semaglutide Research and Development Amylyx Pharmaceuticals Drug Withdrawal Regulatory Updates Regulatory Approval Chemotherapeutic Drugs Gepotidacin Synthetic Biology Sildenafil Synthesis Methods Sarepta Therapeutics Donidalorsen COPD Treatment Existing Drugs FDA Approval
The pact underscores Chinese biotech’s rapid rise in global licensing, with Hengrui leading Phase I trials for the COPD asset before GSK’s later-stage development.
